Silence Therapeutics (SLN) Payables: 2019-2025
Historic Payables for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $17.0 million.
- Silence Therapeutics' Payables rose 191.64% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 191.64%. This contributed to the annual value of $16.4 million for FY2024, which is 5.55% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Payables is $17.0 million, which was up 18.74% from $14.3 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Payables registered a high of $18.8 million during Q1 2025, and its lowest value of -$18.9 million during Q2 2024.
- Moreover, its 3-year median value for Payables was -$13.3 million (2024), whereas its average is -$1.4 million.
- Per our database at Business Quant, Silence Therapeutics' Payables crashed by 287.19% in 2023 and then soared by 241.41% in 2025.
- MRQ analysis of 5 years shows Silence Therapeutics' Payables stood at $14.5 million in 2021, then grew by 1.94% to $14.8 million in 2022, then rose by 4.86% to $15.5 million in 2023, then grew by 5.55% to $16.4 million in 2024, then grew by 3.62% to $17.0 million in 2025.
- Its last three reported values are $17.0 million in Q3 2025, $14.3 million for Q2 2025, and $18.8 million during Q1 2025.